These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24710618)

  • 21. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5-7 September 2012.
    Jones C; Lee CK; Ahn C; Shin J; Knezevic I
    Vaccine; 2013 Sep; 31(41):4466-9. PubMed ID: 23933367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.
    Klugman KP; Gilbertson IT; Koornhof HJ; Robbins JB; Schneerson R; Schulz D; Cadoz M; Armand J
    Lancet; 1987 Nov; 2(8569):1165-9. PubMed ID: 2890805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination against typhoid fever in travellers: a cost-effectiveness approach.
    Papadimitropoulos V; Vergidis PI; Bliziotis I; Falagas ME
    Clin Microbiol Infect; 2004 Aug; 10(8):681-3. PubMed ID: 15301670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Typhoid fever in Fiji: a reversible plague?
    Thompson CN; Kama M; Acharya S; Bera U; Clemens J; Crump JA; Dawainavesi A; Dougan G; Edmunds WJ; Fox K; Jenkins K; Khan MI; Koroivueta J; Levine MM; Martin LB; Nilles E; Pitzer VE; Singh S; Raiwalu RV; Baker S; Mulholland K
    Trop Med Int Health; 2014 Oct; 19(10):1284-92. PubMed ID: 25066005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccination against typhoid fever: results and perspectives].
    Gremiakova TA; Fursova NK; Stepanov AV
    Vestn Ross Akad Med Nauk; 1997; (6):11-6. PubMed ID: 9289271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.
    Tacket CO; Levine MM; Robbins JB
    Vaccine; 1988 Aug; 6(4):307-8. PubMed ID: 3188615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new problem of typhoid fever in Papua New Guinea: how do we deal with it?
    Passey M
    P N G Med J; 1995 Dec; 38(4):300-4. PubMed ID: 9522872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desirability for a typhoid fever vaccine among rural residents, Pemba Island, Tanzania.
    Kaljee LM; Pach A; Thriemer K; Ley B; Jiddawi M; Puri M; Ochiai L; Wierzba T; Clemens J; Ali SM
    Vaccine; 2013 Jun; 31(29):2994-9. PubMed ID: 23664993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatial and temporal clustering of typhoid fever in an urban slum of Dhaka City: Implications for targeted typhoid vaccination.
    Ahmmed F; Khanam F; Islam MT; Kim DR; Kang S; Firoj MG; Aziz AB; Hoque M; Liu X; Jeon HJ; Kanungo S; Chowdhury F; Khan AI; Zaman K; Marks F; Kim JH; Qadri F; Clemens JD; Tadesse BT; Im J
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012273. PubMed ID: 38913735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
    N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Typhoid vaccines.
    Aggarwal A; Dutta AK
    Indian J Pediatr; 2001 Aug; 68(8):733-6. PubMed ID: 11563251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.
    Simanjuntak CH; Paleologo FP; Punjabi NH; Darmowigoto R; Soeprawoto ; Totosudirjo H; Haryanto P; Suprijanto E; Witham ND; Hoffman SL
    Lancet; 1991 Oct; 338(8774):1055-9. PubMed ID: 1681365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans.
    Sahastrabuddhe S; Saluja T
    Clin Infect Dis; 2019 Feb; 68(Suppl 1):S22-S26. PubMed ID: 30767002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers.
    Azze RF; Rodríguez JC; Iniesta MG; Marchena XR; Alfonso VM; Padrón FT
    Vaccine; 2003 Jun; 21(21-22):2758-60. PubMed ID: 12798615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction.
    Carey ME; Diaz ZI; Broadstock M; Bailey R; Bentsi-Enchill AD; Larson HJ
    Clin Infect Dis; 2019 Oct; 69(Suppl 5):S408-S411. PubMed ID: 31612940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and risk factors for typhoid fever in Central Division, Fiji, 2014-2017: A case-control study.
    Prasad N; Jenkins AP; Naucukidi L; Rosa V; Sahu-Khan A; Kama M; Jenkins KM; Jenney AWJ; Jack SJ; Saha D; Horwitz P; Jupiter SD; Strugnell RA; Mulholland EK; Crump JA
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006571. PubMed ID: 29883448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi.
    Meiring JE; Laurens MB; Patel P; Patel P; Misiri T; Simiyu K; Mwakiseghile F; Tracy JK; Masesa C; Liang Y; Henrion M; Rotrosen E; Gmeiner M; Heyderman R; Kotloff K; Gordon MA; Neuzil KM
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S50-S58. PubMed ID: 30845320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.